Volume 22, Number 10—October 2016
Dispatch
Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015
Table
Characteristic | All serogroup W | W:P1.5,2:F1-1:ST11† | Other ST† |
---|---|---|---|
Median age (range), IQR, y |
56 y (<1 mo–89 y), 23–72 y |
56 y (<1 mo–85 y), 25–72 y |
45 y (<1 mo–89 y), 1–84 y |
Indigenous status | |||
Aboriginal or Torres Strait Islander | 0 | 0 | 0 |
Non-Aboriginal | 21 (95) | 16 (100) | 5 (100) |
Unknown |
1 (5) |
0 |
0 |
Manifestation with petechial rash |
2 (10) |
1 (6) |
0 |
Manifestation | |||
Bacteremia | 12 (55) | 8 (50) | 3 (60) |
Septic arthritis | 4 (18) | 3 (19) | 1 (20) |
Meningitis |
1 (5) |
0 |
1 (20) |
Meningitis and bacteremia | 2 (9) | 2 (12) | 0 |
Pneumonia | 2 (9) | 2 (12) | 0 |
Epiglotittis |
1 (5) |
1 (6) |
0 |
Admission to intensive care unit | 7 (32) | 6 (38) | 0 |
Death |
1 (5) |
0 |
0 |
Total | 22 | 16 | 5 |
*Values are no. (%) unless otherwise indicated. IQR, interquartile range; ST, sequence type.
†Excludes 1 patient for whom ST was not determined.
1Current affiliation: Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia.
Page created: September 19, 2016
Page updated: September 19, 2016
Page reviewed: September 19, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.